21 CFR 320.34
§ 320.34 Requirements for batch testing and certification by the Food and Drug Administration.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 320.34, § 320.34 Requirements for batch testing and certification by the Food and Drug Administration, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86463
- Permanent ID
ys:prov:86463@1- SHA-256
21b4bc60509dfd37be3d2c535743334a7b0fb7d14825c8ba61494ebff256b293
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) If the Commissioner determines that individual batch testing by the Food and Drug Administration is necessary to assure that all batches of the same drug product meet an appropriate in vitro test, he shall include in the bioequivalence requirement a requirement for manufacturers to submit samples of each batch to the Food and Drug Administration and to withhold distribution of the batch until notified by the Food and Drug Administration that the batch may be introduced into interstate commerce.
(b) The Commissioner will ordinarily terminate a requirement for a manufacturer to submit samples for batch testing on a finding that the manufacturer has produced four consecutive batches that were tested by the Food and Drug Administration and found to meet the bioequivalence requirement, unless the public health requires that batch testing be extended to additional batches.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.